These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6252153)

  • 1. Cefotaxime in the treatment of lower respiratory tract infections.
    Hänninen P; Toivanen A; Vainio O; Toivanen P
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():181-5. PubMed ID: 6252153
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefotaxime in lower respiratory tract infections compared to cefazolin.
    Miki F; Shiota K
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():169-75. PubMed ID: 6252151
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of long-acting cephalosporins in the treatment of lower respiratory tract infections.
    Lode H; Eller J; Raffenberg M; Mauch H
    Clin Microbiol Infect; 2000; 6 Suppl 3():87-9. PubMed ID: 11449664
    [No Abstract]   [Full Text] [Related]  

  • 4. Cefepime versus cefotaxime in the treatment of lower respiratory tract infections.
    Barckow D; Schwigon CD
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():187-93. PubMed ID: 8150762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized clinical trial of ceftizoxime and cefamandole in the treatment of serious lower respiratory tract infections.
    Rodriguez J; Vazquez GJ; Bermudez RH; Luina A; Ronda CH
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():209-13. PubMed ID: 6296008
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cefotaxime (klaforan) in modern therapy of bacterial infections].
    Khess R; Budanov SV
    Antibiot Khimioter; 1996 Mar; 41(3):44-56. PubMed ID: 8967803
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of severe systemic infections caused by multiple resistant organisms.
    Shah PM; Helm EB; Stille W
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():269-72. PubMed ID: 6252169
    [No Abstract]   [Full Text] [Related]  

  • 8. The evaluation of efficacy and safety of cefotaxime: a review of 2500 cases.
    Young JP; Husson JM; Bruch K; Blomer RJ; Savopoulos C
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():293-300. PubMed ID: 6252175
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of the effectiveness of cefotaxime and cefazolin on respiratory tract infection (author's transl)].
    Kansenshogaku Zasshi; 1980 Sep; 54(9):471-517. PubMed ID: 6263989
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with the fourth generation cephalosporins.
    Giamarellou H
    J Chemother; 1996 Feb; 8 Suppl 2():91-104. PubMed ID: 8738851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefotaxime in bronchopulmonary infections--a clinical and pharmacological study.
    Lode H; Kemmerich B; Gruhlke G; Dzwillo G; Koeppe P; Wagner I
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():193-8. PubMed ID: 6252156
    [No Abstract]   [Full Text] [Related]  

  • 12. Cefoperazone in lower respiratory tract infections.
    Woods CJ; Ellis-Pegler RB
    Drugs; 1981; 22 Suppl 1():96-9. PubMed ID: 6456897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infections in childhood; from respiratory infections to tropical medicine].
    Fortschr Med Suppl; 1993; 144():1-8. PubMed ID: 9260316
    [No Abstract]   [Full Text] [Related]  

  • 14. Cefixime in the treatment of respiratory and urinary tract infections.
    Ludwig E
    Chemotherapy; 1998 Sep; 44 Suppl 1():31-4. PubMed ID: 9797422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral cephalosporins: clinical results in lower respiratory tract infections.
    Pozzi E; Oliva A
    Antibiot Chemother (1971); 1995; 47():123-44. PubMed ID: 8554304
    [No Abstract]   [Full Text] [Related]  

  • 16. Concentrations of cefotaxime in bronchial secretions.
    Morel C; Monrocq N; Besnard Y
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():123-4. PubMed ID: 6252142
    [No Abstract]   [Full Text] [Related]  

  • 17. Cefixime in the treatment of upper respiratory tract infections and otitis media.
    de Lalla F
    Chemotherapy; 1998 Sep; 44 Suppl 1():19-23. PubMed ID: 9797419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Refractory respiratory tract infections. 6. New problems in refractory respiratory tract infections. a. Changes in pathogens and chemotherapy after development of the third generation of cephalosporins].
    Saito A
    Nihon Rinsho; 1987 Mar; 45(3):554-8. PubMed ID: 3298732
    [No Abstract]   [Full Text] [Related]  

  • 19. [Differential use of cephalosporins in treatment of upper and lower respiratory tract infections].
    Dvoretskiĭ LI; Omel'ianovskiĭ VV
    Antibiot Khimioter; 1998; 43(6):24-8. PubMed ID: 9644531
    [No Abstract]   [Full Text] [Related]  

  • 20. A study in general practice of cephradine in respiratory tract infections.
    Marshall BY
    Curr Med Res Opin; 1974; 2(2):72-7. PubMed ID: 4828626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.